By Josh White
Date: Tuesday 24 Feb 2026
(Sharecast News) - OptiBiotix Health announced the start of a clinical study with Hull University Teaching Hospitals NHS Trust on Tuesday, to assess whether its 'WellBiome' prebiotic could improve cardiac surgery outcomes and deliver potential cost savings for the NHS.
By Sharecast
Date: Friday 02 Jan 2026
By Iain Gilbert
Date: Thursday 02 Oct 2025
(Sharecast News) - Optibiotix Health revealed on Thursday that finance director David Blain had acquired 84,053 ordinary shares in the AIM-listed life sciences business.
| Currency | UK Pounds |
| Share Price | 4.93p |
| Change Today | -0.067p |
| % Change | -1.33 % |
| 52 Week High | 18.50 |
| 52 Week Low | 4.80 |
| Volume | 52,777 |
| Shares Issued | 103.30m |
| Market Cap | £5.10m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:51 | 639 @ 4.80p |
| 14:46 | 1,400 @ 4.80p |
| 14:23 | 1,000 @ 4.80p |
| 12:57 | 10,505 @ 4.83p |
| 12:49 | 62 @ 5.20p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research